drug

Japanese pharmaceutical company tries to ban generic versions of Prograf drug to extend its monopoly

Saturday, February 11, 2012 by: Ethan A. Huff, staff writer
Tags: Japan, pharmaceutical company, monopoly

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
The five biggest lies about Ebola being pushed by government and mass media
White House admits staging fake vaccination operation to gather DNA from the public
Why does the CDC own a patent on Ebola 'invention?'
Ultraviolet light robot kills Ebola in two minutes; why doesn't every hospital have one of these?
EXCLUSIVE: Natural News tests flu vaccine for heavy metals, finds 25,000 times higher mercury level than EPA limit for water
Irrefutable proof we are all being sprayed with poison: 571 tons of toxic lead 'chemtrailed' into America's skies every year
Truvia sweetener a powerful pesticide; scientists shocked as fruit flies die in less than a week from eating GMO-derived erythritol
Russia taking McDonald's to court, threatens countrywide shutdown
Oregon man serving prison sentence for collecting rainwater on his own property
The best way to help your body protect itself against Ebola (or any virus or bacteria)
Senator who attacked Doctor Oz over dietary supplements received over $146,000 in campaign contributions from Big Pharma mega-retailer and Monsanto
Global warming data FAKED by government to fit climate change fictions
Healthy 12-year-old girl dies shortly after receiving HPV vaccine
Ebola outbreak may already be uncontrollable; Monsanto invests in Ebola treatment drug company as pandemic spreads
HOAX confirmed: Michelle Obama 'GMOs for children' campaign a parody of modern agricultural politics
Ben & Jerry's switches to non-GMO, Fair Trade ice cream ingredients
W.H.O. contradicts CDC, admits Ebola can spread via coughing, sneezing and by touching contaminated surfaces
Elliot Rodger, like nearly all young killers, was taking psychiatric drugs (Xanax)
Delicious
(NaturalNews) A group of consumers has filed a class-action lawsuit against Japanese pharmaceutical company Astellas Pharma for presenting what they say is a "sham" petition to the U.S. Food and Drug Administration (FDA) to extend the market exclusivity period for its transplant drug Prograf. According to Courthouse News Service, the lawsuit alleges that Astellas filed its petition not out of a concern for public health, but rather to simply extend its monopoly on the overpriced drug, which reportedly rakes in nearly $1 billion a year for Astellas.

Astellas "filed a baseless citizen petition with the FDA with the sole intent of foreclosing market entry by generic competitors, that improperly extended its monopoly and kept Prograf prices at supra-competitive levels," says the complaint. And this petition served as a placeholder for Astellas to continue marketing the drug at inflated prices, as the FDA reportedly took almost two years to provide a proper response.

During this time, Astellas raked in millions more than it would have if the market's exclusivity period would have run its natural course and expired. As a result, plaintiffs in the case, which also include insurance companies that were bilked by artificially-high prices for the drug, are seeking legal remedy for Astellas' alleged criminal behavior.

This is precisely how most drug companies work, though. Not content with simply playing by the same rules as everyone else, they rely on exclusive patents that allow them to make obscene profits on monopoly drugs that cost pennies on the dollar to produce. And as appears to be the case with Astellas, they are more than willing to milk the legal system as much as possible in order to maintain monopoly control over their drugs for as long as possible.

In an attempt to deflect the lawsuits filed against the company, Astellas petitioned for their dismissal citing supposed First Amendment rights. But in her ruling on the case, U.S. District Judge Rya Zobel explained that "[w]hen petitioning conduct is a mere sham to cover what is actually nothing more than an attempt to interfere directly with the business relationship of a competitor, such conduct is not immune."

Prograf is a drug given to transplant patients to prevent rejection of vital organs. It works by deliberately lowering immune function, and its many negative side effects include decreased urination, back pain, bloody urine, chronic fatigue, muscle problems, neurological damage, diabetes, severe allergies, and even death.

Sources for this article include:

http://www.courthousenews.com/2012/02/08/43724.htm

http://www.fiercepharma.com

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.